A Comparative Study to Evaluate the Effect of Yog Basti (Lekhan Aasthapana Basti & Lahshun Taila Anuvasana Basti) and Shamana Aushadha (Vishwadi Guggulu & Aartava Pravartaka Yoga) in the Management of Polycystic Ovarian Syndrome (PCOS)

Abstract

Background: Polycystic Ovarian Syndrome (PCOS) is a multifactorial endocrine disorder characterized by menstrual irregularities, anovulation, hyperandrogenism, and metabolic imbalance. Ayurveda describes PCOS as a manifestation of Artava Dushti and Kapha-Meda vitiation, where both Shodhana (purificatory) and Shamana (palliative) therapies are advocated. The present clinical study was undertaken to comparatively evaluate the efficacy of Yog Basti (Lekhana Aasthapana Basti & Lahshun Taila Anuvasana Basti) and Shamana Aushadha (Vishwadi Guggulu & Aartava Pravartaka Yoga) in the management of PCOS. Aim: To evaluate and compare the therapeutic efficacy of Yog Basti and Shamana Aushadha in the management of PCOS with respect to clinical, hormonal, and metabolic parameters. Materials and Methods: A total of 30 female patients with PCOS were enrolled and evenly distributed into two groups, comprising 15 patients per group. Group I received Yog Basti therapy consisting of Lekhana Aasthapana Basti and Lahshun Taila Anuvasana Basti for three consecutive cycles. Group II was administered Shamana Aushadha, comprising Vishwadi Guggulu and Artava Pravartaka Yoga, orally for the same duration. Assessment was carried out before and after treatment and during follow-ups based on clinical parameters (acne, hirsutism, menstrual irregularity, pain), anthropometric measures (BMI), ovarian morphology, hormonal profile (LH, FSH, AMH, testosterone), and metabolic indices. Results: Both groups showed statistically significant improvement (P<0.001) in major clinical and hormonal parameters such as acne, hirsutism, intermenstrual interval, BMI, ovarian morphology, and LH:FSH ratio. In Group I, maximum relief was observed in no. of follicles (80%), ovarian volume (84.54%), pain (75%), and acne (60.55%) by the third follow-up. In Group II, significant improvement was noted in acne (50.62%), hirsutism (44.22%), pain (73.62%), and ovarian morphology (~82%). Laboratory findings revealed improvement in lipid profile (↓LDL, ↑HDL), reduced ESR, and better insulin regulation in both groups, with Group II showing greater anti-inflammatory response, while Group I showed slightly superior lipid and hormonal correction. Overall, 46.67% of patients were markedly improved, 43.33% moderately improved, 6.67% mildly improved, and 3.33% cured. Conclusion: Both Yog Basti and Shamana Aushadha proved effective in managing the multifactorial aspects of PCOS, including clinical, hormonal, and metabolic parameters. However, Yog Basti (Group I) demonstrated better overall therapeutic response and a higher rate of marked improvement and cure, highlighting the superiority of Shodhana Chikitsa in addressing the root cause and systemic imbalance in PCOS, while Shamana therapy provided supportive, stabilizing, and sustainable results.